Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
MU Ionics and CATL have resolved their patent disputes. They recently signed a licence deal that also impacts Opel, which uses the Chinese battery manufacturer's products in its electric vehicles and
light of day. Plaintiff MED-EL and its opponent Advanced Bionics have reached a settlement to end all ongoing disputes over cochlear implants. MED-EL has confirmed this to JUVE Patent. The opponents were
Germany (March 3, 2025 ip fray article). Infringement litigation is also progressing. For example, ZTE obtained a standard-essential patent (SEP) preliminary injunction in Brazil (February 13, 2025 ip
, projected to be worth $11.4 billion by 2031 (January 2025 IndustryArc report). In parallel, the Qi-related patent market has seen significant momentum, with a number of lawsuits emerging, including in the
billion in 2023, with the U.S. accounting for roughly 66% of those sales (January 2024 Track Drugs Ozempic stats). A huge part of Ozempic’s success is related to Novo Nordisk’s patent filing activity: the
Edwards Lifesciences has secured an important victory before the Unified Patent Court in its long-running heart valve dispute. The Nordic-Baltic division confirmed the patent in amended form and
Generic drug companies cannot launch their enzalutamide products in the Netherlands. In the pan-European dispute over prostate cancer drug Xtandi, the District Court The Hague upheld a basic patent
The global patent disputes between mRNA vaccine manufacturers have once again set the patent community buzzing. While GSK launched several lawsuits at the UPC against Moderna, BioNTech and Pfizer in
Context: In the spring, Nokia determined that licensing discussions with Hisense, Acer and ASUSTeK were not going anywhere, and filed patent infringement lawsuits against the three companies in the
settled part of their Entresto patent fight in the U.S. (court order below). This means they are no longer litigating over this patent: U.S. Patent No. 8,101,659 (“Methods of treatment and
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
